[ Open Now ] 5 Micro Cap Stocks with Massive Upside Potential according to Top Wall Street Analysts

Tickers Insider If you cannot see this email properly, please click [here]( [61fa9913e01c...] --------------------------------------------------------------- [Where is the Next Big "Pot Shot Moonshot" Opportunity Hiding?]( [Discover where the next major cannabis opportunity could be hiding.]([aff_i?offer_...] --------------------------------------------------------------- March 3, 2022 From the desk of Editor (Micro Cap Report) Dear Reader, We just identified 5 Micro Cap stocks that have above average price targets according to the firms listed below. Today’s report includes Analyst coverage from the following firms; Morgan Stanley, Leerink Partners, Barrington, H.C. Wainwright, and Truist Financial. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Floodgates Open on Untapped Cannabis Market of $742 Million]( [9403004f-742...](This under-the-radar pot producer aims to become a premier supplier in one of the world's fastest-growing cannabis markets. [This is the cannabis story 99% of investors are missing.]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Bolt Biotherapeutics, BOLT]( Recent Analyst Action: Matthew Harrison, analyst at Morgan Stanley, reiterates coverage on [Bolt Biotherapeutics (BOLT)](in the Healthcare sector with a Hold rating and a price target of $11 (1 month ago). - Recent Price: $3.16 - Average Analyst Price Target: $25.67 (712.34%) - Market Cap: $117.82M [TipRanks.com]( also reports that [Bolt Biotherapeutics](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $25.67 . The target pricing ranges from a high forecast of $33.00 down to a low forecast of $11.00. [Bolt Biotherapeutics (BOLT)](’s last closing price was $3.16 which would put the average price target at $25.67. Here are 3rd party ratings for [BOLT](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 39% (153 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- ["The Fastest Inflation Gain Since 1983..."]( [1a49a3fe-dcc...](Do you remember what mass inflation was like during the 80's? If so, then you probably realize the importance of protecting your wealth, livelihood, and EVERYTHING you've worked so hard for. [Click Here To See How Elite Investors Are Protecting Their Wealth in This Economy]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [ContraFect, CFRX]( Recent Analyst Action: Roanna Ruiz, analyst at Leerink Partners, reiterates coverage on [ContraFect (CFRX)](in the Healthcare sector with a Buy rating and a price target of $9 (1 week ago). - Recent Price: $3.34 - Average Analyst Price Target: $7.75 (132.04%) - Market Cap: $131.37M [TipRanks.com]( also reports that [ContraFect](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.75 . The target pricing ranges from a high forecast of $9.00 down to a low forecast of $6.50. [ContraFect (CFRX)](’s last closing price was $3.34 which would put the average price target at $7.75. Here are 3rd party ratings for [CFRX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Lincoln Edu, LINC]( Recent Analyst Action: Alexander Paris, analyst at Barrington, reiterates coverage on [Lincoln Edu (LINC)](in the Services sector with a Buy rating and a price target of $9.5 (2 days ago). - Recent Price: $7.85 - Average Analyst Price Target: $11.83 (50.70%) - Market Cap: $211.96M [TipRanks.com]( also reports that [Lincoln Edu](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $11.83 . The target pricing ranges from a high forecast of $16.00 down to a low forecast of $9.50. [Lincoln Edu (LINC)](’s last closing price was $7.85 which would put the average price target at $11.83. Here are 3rd party ratings for [LINC](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Bottom 10% (224 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Technology Revolution: This could be the biggest investment opportunity in a generation]( Spotted near Tesla’s headquarters, a strange new device is being tested…. Some of the biggest Fortune 500 companies in America are already using it… And one tech company’s patented device is the only way to make it all possible. We’re talking about 16,795% gains and beyond. [Click here now for details.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Spectrum Pharmaceuticals, SPPI]( Recent Analyst Action: Edward White, analyst at H.C. Wainwright, reiterates coverage on [Spectrum Pharmaceuticals (SPPI)](in the Healthcare sector with a Buy rating and a price target of $10 (2 weeks ago). - Recent Price: $0.7175 - Average Analyst Price Target: $6.67 (829.62%) - Market Cap: $126.61M [TipRanks.com]( also reports that [Spectrum Pharmaceuticals](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $6.67 . The target pricing ranges from a high forecast of $10.00 down to a low forecast of $4.00. [Spectrum Pharmaceuticals (SPPI)](’s last closing price was $0.7175 which would put the average price target at $6.67. Here are 3rd party ratings for [SPPI](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Bottom 37% (156 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- [Viking Therapeutics, VKTX]( Recent Analyst Action: Joon Lee, analyst at Truist Financial, reiterates coverage on [Viking Therapeutics (VKTX)](in the Healthcare sector with a Buy rating and a price target of $28 (3 weeks ago). - Recent Price: $3.25 - Average Analyst Price Target: $19.40 (496.92%) - Market Cap: $254.68M [TipRanks.com]( also reports that [Viking Therapeutics](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $19.40 . The target pricing ranges from a high forecast of $28.00 down to a low forecast of $10.00. [Viking Therapeutics (VKTX)](’s last closing price was $3.25 which would put the average price target at $19.40. Here are 3rd party ratings for [VKTX](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 39% (153 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [How To Protect Your Wealth, Livelihood, And Retirement From Sky-High Inflation.]( [286726a4-6ca...](Don't let inflation destroy your retirement savings.. Despite seeing the highest inflation rates of the last 40 year doesn't mean that your financial future has to end. There's hope. Discover what these sophisticated investors are doing to "shield" their portfolios. [Yes, Show Me How Savvy Investors are "Shielding" Their Wealth From Record Inflation]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- And there you have it--5 Micro Cap Stocks that are getting attention from some of Wall Street Top Analysts. Sincerely, Editor, DailyMarketMovers.com ___________________________________________________________________________________ Newsletter Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. Sandpiper Marketing Group, LLC | PO Box 407 | Mount Mourne | North Carolina | 28123 | United States | 8458030954 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software